As a global ophthalmic technology company, we take pride at Mynosys in providing surgeons across the world with innovative solutions that promote procedural excellence.
Currently, we’re focusing on our unprecedented ZEPTO® Precision Cataract Surgery platform, as it continues to advance the safety and precision of cataract surgery outcomes. By providing a safe, predictable, effective new way to automate the anterior capsulotomy, the ZEPTO® platform helps surgeons reduce risk, increase edge strength, and improve precision in cataract procedures.
Moving forward, we’ll leverage this micro-surgical technology to create a suite of products for ophthalmic capsular management. Our relentless commitment to developing solutions of the highest quality and technological sophistication is uncompromising – is our dedication to assisting physicians in delivering the best care to patients.
ZEPTO by Mynosys Cellular Devices Inc.